Incidence of anemia in leprosy patients treated with dapsone. 1984

S Puavilai, and S Chutha, and N Polnikorn, and P Timpatanapong, and P Tasanapradit, and S Charuwichitratana, and A Boonthanom, and H Wongwaisayawan

UI MeSH Term Description Entries
D007918 Leprosy A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid. Hansen's Disease,Hansen Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003622 Dapsone A sulfone active against a wide range of bacteria but mainly employed for its actions against MYCOBACTERIUM LEPRAE. Its mechanism of action is probably similar to that of the SULFONAMIDES which involves inhibition of folic acid synthesis in susceptible organisms. It is also used with PYRIMETHAMINE in the treatment of malaria. (From Martindale, The Extra Pharmacopoeia, 30th ed, p157-8) Diaminodiphenylsulfone,Sulfonyldianiline,4,4'-Diaminophenyl Sulfone,Avlosulfone,DADPS,Dapsoderm-X,Dapson-Fatol,Diaphenylsulfone,Disulone,Sulfona,4,4' Diaminophenyl Sulfone,Sulfone, 4,4'-Diaminophenyl
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000740 Anemia A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN. Anemias

Related Publications

S Puavilai, and S Chutha, and N Polnikorn, and P Timpatanapong, and P Tasanapradit, and S Charuwichitratana, and A Boonthanom, and H Wongwaisayawan
September 1979, Leprosy review,
S Puavilai, and S Chutha, and N Polnikorn, and P Timpatanapong, and P Tasanapradit, and S Charuwichitratana, and A Boonthanom, and H Wongwaisayawan
February 2002, East African medical journal,
S Puavilai, and S Chutha, and N Polnikorn, and P Timpatanapong, and P Tasanapradit, and S Charuwichitratana, and A Boonthanom, and H Wongwaisayawan
January 1986, Indian journal of leprosy,
S Puavilai, and S Chutha, and N Polnikorn, and P Timpatanapong, and P Tasanapradit, and S Charuwichitratana, and A Boonthanom, and H Wongwaisayawan
November 1975, The American journal of tropical medicine and hygiene,
S Puavilai, and S Chutha, and N Polnikorn, and P Timpatanapong, and P Tasanapradit, and S Charuwichitratana, and A Boonthanom, and H Wongwaisayawan
January 2001, Indian journal of leprosy,
S Puavilai, and S Chutha, and N Polnikorn, and P Timpatanapong, and P Tasanapradit, and S Charuwichitratana, and A Boonthanom, and H Wongwaisayawan
March 1974, The American journal of tropical medicine and hygiene,
S Puavilai, and S Chutha, and N Polnikorn, and P Timpatanapong, and P Tasanapradit, and S Charuwichitratana, and A Boonthanom, and H Wongwaisayawan
January 1990, The British journal of ophthalmology,
S Puavilai, and S Chutha, and N Polnikorn, and P Timpatanapong, and P Tasanapradit, and S Charuwichitratana, and A Boonthanom, and H Wongwaisayawan
September 2012, Leprosy review,
S Puavilai, and S Chutha, and N Polnikorn, and P Timpatanapong, and P Tasanapradit, and S Charuwichitratana, and A Boonthanom, and H Wongwaisayawan
September 1997, Pharmaceutica acta Helvetiae,
S Puavilai, and S Chutha, and N Polnikorn, and P Timpatanapong, and P Tasanapradit, and S Charuwichitratana, and A Boonthanom, and H Wongwaisayawan
January 1997, Nephron,
Copied contents to your clipboard!